722 related articles for article (PubMed ID: 27586797)
1. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
Zhong Z; Sanchez-Lopez E; Karin M
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):12-6. PubMed ID: 27586797
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms regulating NLRP3 inflammasome activation.
Jo EK; Kim JK; Shin DM; Sasakawa C
Cell Mol Immunol; 2016 Mar; 13(2):148-59. PubMed ID: 26549800
[TBL] [Abstract][Full Text] [Related]
3. The NLRP3 Inflammasome as a Pharmacological Target.
Marchetti C
J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
[TBL] [Abstract][Full Text] [Related]
4. The NLRP3 inflammasome in kidney disease and autoimmunity.
Hutton HL; Ooi JD; Holdsworth SR; Kitching AR
Nephrology (Carlton); 2016 Sep; 21(9):736-44. PubMed ID: 27011059
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
Buckley LF; Libby P
J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 Inflammasome in Acute Myocardial Infarction.
Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
[TBL] [Abstract][Full Text] [Related]
7. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases.
Zhang Y; Yang W; Li W; Zhao Y
Front Immunol; 2021; 12():732933. PubMed ID: 34707607
[TBL] [Abstract][Full Text] [Related]
9. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
Takahashi M
J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
[TBL] [Abstract][Full Text] [Related]
10. Interplay Between NLRP3 Inflammasome and Autophagy.
Biasizzo M; Kopitar-Jerala N
Front Immunol; 2020; 11():591803. PubMed ID: 33163006
[TBL] [Abstract][Full Text] [Related]
11. The NLRP3 inflammasome in acute myocardial infarction.
Toldo S; Abbate A
Nat Rev Cardiol; 2018 Apr; 15(4):203-214. PubMed ID: 29143812
[TBL] [Abstract][Full Text] [Related]
12. Mitophagy: a balance regulator of NLRP3 inflammasome activation.
Kim MJ; Yoon JH; Ryu JH
BMB Rep; 2016 Oct; 49(10):529-535. PubMed ID: 27439607
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria: Sovereign of inflammation?
Tschopp J
Eur J Immunol; 2011 May; 41(5):1196-202. PubMed ID: 21469137
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-Endoplasmic Reticulum Contact Sites Mediate Innate Immune Responses.
Misawa T; Takahama M; Saitoh T
Adv Exp Med Biol; 2017; 997():187-197. PubMed ID: 28815531
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 inflammasome as a key driver of vascular disease.
Takahashi M
Cardiovasc Res; 2022 Jan; 118(2):372-385. PubMed ID: 33483732
[TBL] [Abstract][Full Text] [Related]
16. X-11-5-27, a daidzein derivative, inhibits NLRP3 inflammasome activity via promoting autophagy.
Zhou W; Liu X; Cheng K; Zhang X; Lu J; Hu R
Exp Cell Res; 2017 Nov; 360(2):320-327. PubMed ID: 28942022
[TBL] [Abstract][Full Text] [Related]
17. NLRP3: A promising therapeutic target for autoimmune diseases.
Shen HH; Yang YX; Meng X; Luo XY; Li XM; Shuai ZW; Ye DQ; Pan HF
Autoimmun Rev; 2018 Jul; 17(7):694-702. PubMed ID: 29729449
[TBL] [Abstract][Full Text] [Related]
18. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
Martínez GJ; Celermajer DS; Patel S
Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 Inflammasome in Cardioprotective Signaling.
Zuurbier CJ
J Cardiovasc Pharmacol; 2019 Oct; 74(4):271-275. PubMed ID: 31356546
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder.
Alcocer-Gómez E; Casas-Barquero N; Williams MR; Romero-Guillena SL; Cañadas-Lozano D; Bullón P; Sánchez-Alcazar JA; Navarro-Pando JM; Cordero MD
Pharmacol Res; 2017 Jul; 121():114-121. PubMed ID: 28465217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
